Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Hungary Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20033
20041
20052
20062
20082
20101
20142
20151
20161
20172
20181
20211
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated7
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi6
Boehringer Ingelheim3
Daiichi Sankyo2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Anthos Therapeutics, Inc.1
AstraZeneca1
Atrial Fibrillation Network1
Bayer1
Bristol-Myers Squibb1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation26
Atrial Flutter4
Stroke4
Arrhythmias, Cardiac2
Cardiovascular Diseases2
Embolism2
Acute Coronary Syndrome1
Atherosclerosis1
Coronary Artery Disease1
Heart Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.